Ronald G. Gelbman is Director at HAEMONETICS CORP (HAE). They have made 18 open-market trades across 2 companies since 2006, most recently 2019-11-11.
CIK 0001210616
1 open-market purchase totalling $200K since 2006, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | SELL | 2019-11-11 | 2019-11-13 | $118.26 | $4.0M | +0.6% | -2.6% | -1.1% |
| HAE | SELL | 2019-08-08 | 2019-08-12 | $134.15 | $455K | +0.8% | -7.1% | -10.6% |
| HAE | SELL | 2019-02-15 | 2019-02-19 | $86.52 | $1.4M | +0.7% | +0.7% | +14.4% |
| HAE | SELL | 2018-12-14 | 2018-12-18 | $103.02 | $892K | -1.2% | -1.6% | -15.9% |
| HAE | SELL | 2017-11-16 | 2017-11-17 | $56.69 | $314K | -0.3% | +0.6% | +21.2% |
| HAE | SELL | 2017-03-24 | 2017-04-27 | $40.00 | $343K | +0.6% | -2.6% | -6.0% |
| HAE | SELL | 2016-12-12 | 2016-12-14 | $40.30 | $458K | +0.3% | -0.0% | -4.9% |
| HAE | SELL | 2015-03-05 | 2015-03-06 | $44.76 | $345K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2014-06-12 | 2014-06-13 | $34.00 | $312K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2014-03-06 | 2014-03-07 | $36.17 | $434K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2012-12-13 | 2012-12-17 | $40.07 | $453K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2012-08-23 | 2012-08-27 | $71.90 | $431K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2012-05-17 | 2012-05-21 | $71.49 | $177K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2010-12-23 | 2010-12-28 | $64.22 | $385K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2010-05-11 | 2010-05-13 | $57.02 | $513K | -4.4% | -2.0% | -2.0% |
| HAE | SELL | 2009-09-18 | 2009-09-21 | $55.78 | $335K | -4.4% | -2.0% | -2.0% |
| HAE | BUY | 2006-08-02 | 2006-08-03 | $44.99 | $200K | -4.4% | -2.0% | -2.0% |
| SERO | SELL | 2006-03-13 | 2006-03-15 | $24.52 | $42K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.